Zovirax Interactions
Showing entire list of all interactions, including brand names and combination drugs.
Go back to interactions summary
Medications known to interact with Zovirax
A
- abacavir / lamivudine / zidovudine
- AccessPak for HIV PEP Basic (emtricitabine / tenofovir)
- AccessPak for HIV PEP Expanded with Kaletra (emtricitabine / lopinavir / ritonavir / tenofovir)
- AccessPak for HIV PEP Expanded with Viracept (emtricitabine / nelfinavir / tenofovir)
- adefovir
- Aerolate III (theophylline)
- Aerolate JR (theophylline)
- Aerolate SR (theophylline)
- Afinitor (everolimus)
- Afinitor Disperz (everolimus)
- Alimta (pemetrexed)
- Ami-rax (ephedrine / hydroxyzine / theophylline)
- aminophylline
- aminophylline / amobarbital / ephedrine
- aminophylline / ephedrine / guaifenesin / phenobarbital
- aminophylline / ephedrine / phenobarbital / potassium iodide
- aminophylline / guaifenesin
- ampicillin / probenecid
- Angiografin (diatrizoate)
- Apriso (mesalamine)
- Aquaphyllin (theophylline)
- Asacol (mesalamine)
- Asacol HD (mesalamine)
- Asbron G (guaifenesin / theophylline)
- Asmalix (theophylline)
- Astagraf XL (tacrolimus)
- Asthmacon (aminophylline / amobarbital / ephedrine)
- Atripla (efavirenz / emtricitabine / tenofovir)
- avibactam / ceftazidime
- Avycaz (avibactam / ceftazidime)
- Azulfidine (sulfasalazine)
- Azulfidine EN-tabs (sulfasalazine)
More about Zovirax (acyclovir)
- Zovirax consumer information
- Check interactions
- Compare alternatives
- Reviews (17)
- Drug images
- Latest FDA alerts (3)
- Side effects
- Dosage information
- During pregnancy
- Drug class: purine nucleosides
- Breastfeeding
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.